Related Experiment Video
Updated: Jul 26, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Diagnostic Value and Prognosis Significance of Cerebrospinal Fluid Examination by Flow Cytometry in Pediatric Acute
Lian Xue1, Qianwen Shang1, Aidong Lu1
1Pediatric Department, The People's Hospital of Peking University, Beijing, China.
Abstract:
Purpose: To explore the diagnostic value and the prognostic significance of cerebrospinal fluid (CSF) examination by flow cytometry (FC) in children with central nervous system leukemia (CNSL). Method: This is a retrospective observational study. We select 986 pediatric patients with newly diagnosed acute lymphoblastic leukemia from January 2012 to December 2018 as the research objects and analyze the sensitivity and specificity of different methods for diagnosing CNSL. The recurrence rate and survival rate of CNSL in different groups were compared. Results: Among the 986 cases, 31 cases (positive rate of 3.14%) were positive by FC, and the cytospin-based cytomorphology (CC) test was positive in 6 cases (positive rate of 0.61%). CC combined with FC might improve the diagnostic sensitivity (from 30% to 65%, π₯2 value was 5.143, Pββ=ββ.016). The 2-year event-free survival (EFS) of 31 FCββ+ββchildren was 59.5%ββΒ±ββ9.2%, and that of 955 FCβ- children was 74.1%ββΒ±ββ1.8% (Pββ=ββ.004). The 2-year overall survival (OS) of the 2 groups were 63.6%ββΒ±ββ9.7% and 80.2%ββΒ±ββ1.5%, respectively (Pββ=ββ.004). In order to exclude the influence of CNSL, we divided the patients into 3 groups: CNSL group and non-CNSL group with CSF FCβ+β, FCβ- group. There was no significant difference in EFS between FCβ- group and non-CNSL group with FCββ+ββ(2-year EFS were 74.1%ββΒ±ββ1.8% and 68.7%ββΒ±ββ9.8%, respectively, Pββ=ββ.142), and there was a significant difference in OS (2-year OS were 80.2%ββΒ±ββ1.5% and 67.5%ββΒ±ββ10.3%, respectively, Pββ=ββ.029). Conclusion: The test of FC combined with CC may improve the diagnostic sensitivity of CNSL. The EFS and OS of children with FCββ+ββare worse than those of children with FCβ-. However, for those patients with non-CNSL, but only FCββ+ββat the initial diagnosis, the EFS is not significantly affected by strengthening systemic chemotherapy and increasing the number of intrathecal injections.
More Related Videos
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018